J9048 Injection, bortezomib freseniuskab
J-Codes
Also known as: bortezomib, Fresenius Kabi
Intravenous injection of bortezomib (Fresenius Kabi brand), a proteasome inhibitor chemotherapy agent, dosed per 0.1 milligram.
Clinical Context
Brand-specific formulation of bortezomib for multiple myeloma and mantle cell lymphoma.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.